Navigation Links
ThermoGenesis Presentation at Rodman & Renshaw Conference
Date:9/7/2011

RANCHO CORDOVA, Calif., Sept. 7, 2011 /PRNewswire/ -- ThermoGenesis Corp. (NASDAQ: KOOL), a leading supplier of innovative products and services that process and store adult stem cells, announced today that it will be participating in the Rodman & Renshaw 13th Annual Healthcare Conference on Tuesday, September 13, 2011.

The Company's presentation by Mr. Matthew T. Plavan, the Company's Chief Financial Officer and Executive Vice President, Business Development, will begin at 10:00 am, Eastern Standard Time (7:00 am, Pacific Standard Time), and will be held at the Waldorf Astoria, located at 301 Park Avenue, New York, NY 10022.

Webcast

The presentation will be webcast live and archived for 90 days, streaming video and PowerPoint slides.  Access is available by logging on to the conference website http://wsw.com/webcast/rrshq20/kool or by going to the Company's website www.thermogenesis.com. It is recommended that interested parties register at least 15 minutes prior to the start of the presentation to ensure timely access.

About ThermoGenesis Corp.

ThermoGenesis Corp. (www.thermogenesis.com) is a leader in developing and manufacturing automated blood processing systems and disposable products that enable the manufacture, preservation and delivery of cell and tissue therapy products.

ThermoGenesis Corp.
Web site: http://www.thermogenesis.com
Contact: Investor Relations
+1-916-858-5107, or
ir@thermogenesis.com


'/>"/>
SOURCE ThermoGenesis Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. ThermoGenesis Names Former Applied Imaging CEO Robin Stracey to Board of Directors, Replacing Dr. Mahendra Rao
2. ThermoGenesis Announces Webcast of Presentation at OnemedForum Conference
3. ThermoGenesis Reports Third Quarter Fiscal 2011 Results; Major Progress Achieved in China & India
4. ThermoGenesis Corp. to Announce Third Quarter Fiscal 2011 Results On May 5, 2011
5. ThermoGenesis Announces Registration of Res-Q in India; Commercial Sales Expected to Begin in Current Quarter
6. Major China Regenerative Medicine Company Adopts ThermoGenesis Cord Blood Stem Cell Processing And Storage Technologies
7. ThermoGenesis Reports Second Quarter 2011 Results; Increased Presence in China
8. ThermoGenesis Announces Agreement for AXP and BioArchive Cord Blood Systems With Major Chinese Stem Cell Company
9. ThermoGenesis Corp. to Announce Second Quarter Fiscal 2011 Results on February 10, 2011
10. ThermoGenesis Corp. and TotipotentSC Receive Approval for Phase Ib Clinical Trial of Res-Q™ 60 BMC for Treatment of Critical Limb Ischemia
11. ThermoGenesis Corp. Files Shelf Registration Statement on Form S-3
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... , Sept. 15, 2014 /CNW/ - Health Minister Rona ... will make available for donation over $2.5 million in personal ... aid in the global response to the Ebola outbreak in ... WHO reported a shortage of equipment in the affected countries ... by front-line workers in the affected countries. ...
(Date:9/15/2014)... 15, 2014 /PRNewswire/ -  Pivotal Therapeutics Inc. (OTCQX:PVTTF; ... company with a focus on Omega-3 therapies for ... the Board of Directors approved the granting of ... the close of business on Friday, September 12, ... common shares of the Company were granted in ...
(Date:9/15/2014)... /PRNewswire-iReach/ -- Asthma is a chronic inflammatory lung ... most commonly starts in childhood. It is a ... airways, leading to airflow limitation and airway hyper-responsiveness ... endogenous and exogenous irritants. Exposure to irritants instigates ... the airways, tightening of the respiratory muscles, and ...
Breaking Medicine Technology:Canada offers essential protective equipment to help stop the spread of Ebola in West Africa 2Canada offers essential protective equipment to help stop the spread of Ebola in West Africa 3Pivotal Therapeutics Grants Incentive Stock Options 2Asthma Market to Reach 161.02 million Cases in 10MM by 2023 2Asthma Market to Reach 161.02 million Cases in 10MM by 2023 3Asthma Market to Reach 161.02 million Cases in 10MM by 2023 4Asthma Market to Reach 161.02 million Cases in 10MM by 2023 5
... DIEGO, Feb. 29, 2012  Polaris Group (Polaris) today announced ... Phase 1 clinical trial evaluating its lead cancer therapeutic, ... emphasis on leukemia, lymphoma and sarcoma cancers. These three ... in the pediatric population. Patients with advanced ...
... Md., Feb. 29, 2012  Northwest Biotherapeutics (OTC.BB: NWBO) (NW ... Ph.D., MA, MBA, will be presenting at the Cancer ... pm ET on Wednesday, February 29, 2012, in Boston, Massachusetts ... (Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO ) ...
Cached Medicine Technology:Polaris Group Doses First Patient in Phase 1 Clinical Trial of Lead Therapeutic Candidate ADI-PEG 20 in Pediatric Patients with Emphasis on Leukemia, Lymphoma and Sarcoma 2Polaris Group Doses First Patient in Phase 1 Clinical Trial of Lead Therapeutic Candidate ADI-PEG 20 in Pediatric Patients with Emphasis on Leukemia, Lymphoma and Sarcoma 3NW Bio to Present at the Cancer Immunotherapy Summit 2NW Bio to Present at the Cancer Immunotherapy Summit 3NW Bio to Present at the Cancer Immunotherapy Summit 4
(Date:9/16/2014)... 16, 2014 Wholelifeinsurancecompanies.org has released a ... life insurance with a bad heart condition. , Clients ... affordable life insurance if they compare quotes. Most agencies ... decision depend on the actual and past medical condition. ... caused several heart attacks in the past, his or ...
(Date:9/16/2014)... comparison of five-year sexual function outcomes, as ... radiotherapy (EBRT) versus combination EBRT plus brachytherapy, ... therapy makes cure possible without compromising long-term ... at the American Society for Radiation Oncology,s ... study examined the patient-reported outcomes of 91 ...
(Date:9/16/2014)... than any other workplace incident, a statistic that transport ... conference being hosted by QUT,s Centre for Accident Research ... Safety in Transport Conference (OSIT) to be held on ... together experts from all facets of transport safety including ... and safety. , CARRS-Q research fellow Darren Wishart said ...
(Date:9/16/2014)... have developed a new cocktail that is highly ... pluripotent stem cells. , Regenerative medicine is a ... lost or damaged cells, tissues or organs through ... embryos can trigger ethical concerns, a good solution ... state using a combination of reprogramming factors. ...
(Date:9/16/2014)... 2014 An experimental positron emission tomography ... while a person is still alive, according to a ... at Mount Sinai, and at Molecular Neuroimaging (MNI) LLC ... journal Translational Psychiatry. , Specifically, the study results suggest ... is designed to latch onto a protein called tau ...
Breaking Medicine News(10 mins):Health News:No Exam Life Insurance for Clients Who Have a Bad Heart Condition! 2Health News:Prostate cancer patients surveyed 5 years after vessel-sparing RT report preserved sexual function 2Health News:Prostate cancer patients surveyed 5 years after vessel-sparing RT report preserved sexual function 3Health News:CARRS-Q Host International Transport Safety Conference 2Health News:Scientists create therapy-grade stem cells using new cocktail to reprogram adult cells 2Health News:Neuroimaging Technique Identifies Concussion-Related Brain Disease in Living Brain 2Health News:Neuroimaging Technique Identifies Concussion-Related Brain Disease in Living Brain 3Health News:Neuroimaging Technique Identifies Concussion-Related Brain Disease in Living Brain 4
... His Royal Highness, The Duke of York,was the ... to mark the United States,launch of UK-based specialty ... US product, Sancuso, is currently under,consideration for licensing ... (Photo: http://www.newscom.com/cgi-bin/prnh/20080214/NYTH111 ), Prince Andrew ...
... validity of self-reported tobacco use in research, care , , ... more likely than younger ones to deny they smoke ... That,s the conclusion of a study that analyzed data ... took part in the third National Health and Nutrition ...
... Dividend, ACTON, Mass., Feb. 14 Psychemedics,Corporation (Amex: ... results for the period ended December 31, 2007, which ... The Company,also announced a quarterly dividend of $0.15 per ... 2008 to be paid on March 21, 2008.,This will ...
... Weight Watchers,International, Inc. (NYSE: WTW ) today announced results ... 2007., Fourth Quarter 2007 Results, For the fourth ... $344.0 million. Fully diluted earnings per share in the fourth,quarter ... period. The prior,year included a benefit of $0.06 per share ...
... N.J., Feb. 14 TeamStaff, Inc.,(Nasdaq: TSTF ), ... announced its financial results for the first,quarter ended December ... months ended December 31, 2007 was,$0.1 million as compared ... last year. Income from continuing operations was $0.04 million ...
... 14 /PRNewswire-USNewswire/ - The Foundation,for Taxpayer and Consumer ... HMO,regulator calling for swift action to end Blue ... medical records for any,excuse to dump patients who ... the Los Angeles Times on Wednesday,that the practice ...
Cached Medicine News:Health News:His Royal Highness The Duke of York Helps Launch UK-Based Pharmaceutical Company, ProStrakan, in the United States 2Health News:His Royal Highness The Duke of York Helps Launch UK-Based Pharmaceutical Company, ProStrakan, in the United States 3Health News:Older Smokers More Likely to Deny Habit 2Health News:Psychemedics Corporation Announces Year End Results Record Annual and Quarterly Revenue 2Health News:Psychemedics Corporation Announces Year End Results Record Annual and Quarterly Revenue 3Health News:Psychemedics Corporation Announces Year End Results Record Annual and Quarterly Revenue 4Health News:Psychemedics Corporation Announces Year End Results Record Annual and Quarterly Revenue 5Health News:Psychemedics Corporation Announces Year End Results Record Annual and Quarterly Revenue 6Health News:Weight Watchers Announces Fourth Quarter and Full Year 2007 Results 2Health News:Weight Watchers Announces Fourth Quarter and Full Year 2007 Results 3Health News:Weight Watchers Announces Fourth Quarter and Full Year 2007 Results 4Health News:Weight Watchers Announces Fourth Quarter and Full Year 2007 Results 5Health News:Weight Watchers Announces Fourth Quarter and Full Year 2007 Results 6Health News:Weight Watchers Announces Fourth Quarter and Full Year 2007 Results 7Health News:TeamStaff Reports First Quarter Net Income and $0.7 Million Income Improvement From Continuing Operations Over Prior Year 2Health News:TeamStaff Reports First Quarter Net Income and $0.7 Million Income Improvement From Continuing Operations Over Prior Year 3Health News:TeamStaff Reports First Quarter Net Income and $0.7 Million Income Improvement From Continuing Operations Over Prior Year 4Health News:TeamStaff Reports First Quarter Net Income and $0.7 Million Income Improvement From Continuing Operations Over Prior Year 5Health News:TeamStaff Reports First Quarter Net Income and $0.7 Million Income Improvement From Continuing Operations Over Prior Year 6Health News:TeamStaff Reports First Quarter Net Income and $0.7 Million Income Improvement From Continuing Operations Over Prior Year 7Health News:TeamStaff Reports First Quarter Net Income and $0.7 Million Income Improvement From Continuing Operations Over Prior Year 8Health News:TeamStaff Reports First Quarter Net Income and $0.7 Million Income Improvement From Continuing Operations Over Prior Year 9Health News:FTCR: Gov. Schwarzenegger Must Follow Through on Call to Ban Blue Cross From Using Doctors as Double-Agents to Dump Sick Patients 2
... three-dimensional VCS technology, providing ... efficiency in white cell ... With its reputation for ... is an affordable solution ...
Creatinine Test Kit (enzymatic), Wavelength: 340 nm. Linear range: up to 20 mg/dL....
For the quantitative determination of Creatine Kinase in serum....
For the qualitative determination of magnesium in serum....
Medicine Products: